New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis)

Current Opinion in Rheumatology

Volumn 16, Issue 3, 2004, Pages 287-292

  Sarzi Puttini, Piercarlo ^a   Atzeni, Fabiola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Diffuse idiopathic skeletal hyperostosis; Forestier's disease; Matrix Gla protein; Ossification of ligamentum flavum; Ossification of posterior longitudinal ligament

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; ISOTRETINOIN; OSTEOCALCIN; URIC ACID;

ANKYLOSING HYPEROSTOSIS; ANKYLOSING SPONDYLITIS; BODY MASS; BONE CELL; BONE RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS; DISEASE ASSOCIATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; JOINT; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OSSIFICATION; OSTEOARTHRITIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REITER SYNDROME; REVIEW; RISK FACTOR; SPINE; URIC ACID BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; HYPEROSTOSIS, DIFFUSE IDIOPATHIC SKELETAL; OSTEOGENESIS;

EID: 2142712605     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200405000-00021     Document Type: Review

References (54)

1. Forestier J, Rotes-Querol J: Senile ankylosing hyperostosis of the spine. Ann Rheum Dis 1950, 9:321-330.
2. Mader R: Diffuse idiopathic skeletal hyperostosis: a distinct clinical entity. Isr Med Assoc J 2003, 5:506-508. This article provides a clear and definitive definition of DISH as a clinical entity that is distinct from osteoarthrosis on the basis of epidemiologic, pathogenetic, clinical, and radiologic data.
3. Belanger TA, Rowe DE: Diffuse idiopathic skeletal hyperostosis: musculoskeletal manifestations. J Am Acad Orthop Surg 2001, 9:258-267.
4. Resnick D, Shapiro RF, Wiesner KB, et al.: Diffuse idiopathic skeletal hyperostosis (DISH): ankylosing hyperostosis of Forestier and Rotés Querol. Semin Arthritis Rheum 1978, 7:153-187.
5. Benjamin M, Kumai T, Milz S, et al.: The skeletal attachment of tendons - tendon "entheses." Comp Biochem Physiol A Mol integr Physiol 2002, 133:931-945.
6. Resnick D, Niwayama G: Radiographic and pathologic features of spinal involvement in diffuse idiopathic skeletal hyperostosis (DISH). Radiology 1976, 119:559-568.
7. Utsinger PD: Diffuse idiopathic skeletal hyperostosis Clin Rheum Dis 1985, 7:153-187.
8. Ehara S, Shimamura T, Nakamura R, et al.: Paravertebral ligamentous ossification: DISH, OPLL and OLF. Eur J Radiol 1998, 27:196-205.
9. Resnick D, Guerra J, Robinson CA, et al.: Association of diffuse idiopathic skeletal hyperostosis (DISH) and calcification and ossification of the posterior longitudinal ligament. AJR Am J Roentgenol 1978, 131:1049-1053.
10. Hukuda S, Mochizuki T, Ogata M, et al.: The pattern of spinal and extraspinal hyperostosis in patients with ossification of the posterior longitudinal ligament and the ligamentum flavum causing myelopathy. Skeletal Radiol 1983, 10:79-85.
11. Sharma RR, Mahapatra A, Pawar SJ, et al.: Spinal cord and cauda equina compression in 'DISH.' Neurol India 2001, 49:148-152.
12. Federici A, Sgadari A, Savo A, et al.: Diffuse idiopathic skeletal hyperostosis: an uncommon case of dysphagia in an older adult. Aging Clin Exp Res 2003, 15:343-346. This case report shows that DISH is not only responsible for the ossification of the anterior longitudinal ligament but, in the elderly, can also give rise to complex clinical pictures that need to be suspected and identified.
13. Ebo D, Goethals L, Bracke P, et al.: Dysphagia in a patient with giant osteophytes: case presentation and review of the literature. Clin Rheumatol 2000, 19:70-72.
14. Takasita M, Matsumoto H, Uchinou S, et al.: Atlantoaxial subluxation associated with ossification of posterior longitudinal ligament of the cervical spine. Spine 2000, 25:2133-2136.
15. Littlejohn JO, Urowitz MB, Smythe HA, et al.: Radiographic features of the hand in diffuse idiopathic skeletal hyperostosis (DISH). Diagn Radiol 1981, 140:623-629.
16. Beyeler C, Schlapbabach P, Gerber NJ, et al.: Diffuse idiopathic skeletal hyperostosis (DISH) of the shoulder. A cause of shoulder pain? Br J Rheumatol 1990, 29:349-353.
17. Di Girolamo C, Pappone N, Rengo C, et al.: Intervertebral disc lesions in diffuse idiopathic skeletal hyperostosis (DISH). Clin Exp Rheum 2001, 19:310-312.
18. Gerster JC: Achilles tendinitis as a severe clinical feature of diffuse idiopathic skeletal hyperostosis. J Rheumatol 1995, 22:1212-1214.
19. Julkun H, Heinonen OP, Knekt P, et al.: The epidemiology of hyperostosis of the spine together with its symptoms and related mortality in a general population. Scand J Rheumatol 1975, 4:23-27.
20. Cassim B, Mody GM, Rubin DL: The prevalence of diffuse idiopathic skeletal hyperostosis in African blacks. Br J Rheumatol 1990, 29:131-132.
21. Weinfeld RM, Olson PN, Maki DD, et al.: The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in two large American Midwest metropolitan hospital populations. Skeletal Radiol 1997, 26:222-225.
22. Kiss C, Szilagyi M, Paksy A, et al.: Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study. Rheumatology 2002, 41:27-30.
23. Troillet N, Gerster JC: Forestier disease and metabolism disorders. A prospective controlled study of 25 cases. Rev Rhum Ed Fr 1993, 60:274-279.
24. Vezyroglou G, Mitropoulos A, Antoniadis C: A metabolic syndrome in diffuse idiopathic skeletal hyperostosis. A controlled study. J Rheumatol 1996, 23:672-676.
25. Dougados M, Leporho MA, Esmilaire L, et al.: Taux plasmatiques des vitamines A et E au cours de la maladie hyperostosique, la spondyloarthrite ankylosante, et la polyarthrite rheumatoide. Rev Rhum Mal Osteoartic 1988, 55:251-254.
26. Denko CW, Boja B, Moskowitz RW: Growth promoting peptides in osteoarthritis and DISH. J Rheumatol 1994, 21:1725.
27. Oppenheimer A: Calcification and ossification of vertebral ligaments: roentgen study of pathogenesis and clinical significance. Radiology 1942, 38:160.
28. Smith CF, Pugh DG, Polley HF: Physiologic vertebral ligamentous calcification: an aging process. AJR Am J Roentgenol 1955, 74:1049.
29. El Miedany YM, Wassif G, El Baddini M: Diffuse idiopathic skeletal hyperostosis (DISH): is it of vascular aetiology? Clin Exp Rheumatol 2000, 18:193-200.
30. Fawcett DW: A Textbook of Histology, edn 12. Chapman & Hall 1994:224-233.
31. Vetter U, Zapf J, Heit W, et al.: Human fetal and adult chondrocytes. Effects of insulin-like growth factors I and II, insulin and growth hormone on clonal growth. J Clin Invest 1986, 77:1903-1908.
32. Denko CW, Boja B, Moskowitz RW: Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis - insulin, insulin-like growth factor-I, growth hormone. J Rheumatol 1994, 21:1725-1730.
33. Kodama T, Matsunaga S, Taketomi E, et al.: Retinoid and bone metabolic markers in ossification of the posterior longitudinal ligament. In Vivo 1998, 12:339-344.
34. Kosaka T, Imakiire A, Mizuno F, et al.: Activation of nuclear factor kappaB at the onset of ossification of the spinal ligaments. J Orthop Sci 2000, 5:572-578.
35. 2/cAMP system.
36. Rutsch F, Terkeltaub R: Parallels between arterial and cartilage calcification: what understanding artery calcification can teach us about chondrocalcinosis. Curr Opin Rheumatol 2003, 15:302-310. This comprehensive review summarizes the similar processes that contribute to the development of both arterial and articular cartilage calcification, including low-grade tissue inflammation, genetic deficiencies of calcification inhibitors, and altered homeostasis of inorganic solutes.
37. El-Maadawy S, Kaartinen MT, Schinke T, et al.: Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res 2003, 44:272-278.
38. Zebboudj AF, Imura M, Bostrom K: Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 2002, 8; 277:6 4388-4394.
39. Dhore CR, Cleutjens JP, Lutgens E, et al.: Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001, 21:1998-2003.
40. Zebboudj AF, Shin V, Bostrom K, et al.: Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 2003, 90:756-765. This study provides a further demonstration of the binding between MGP and BMP-2, and demonstrates its role in regulating bone synthesis in calcifying vascular cells.
41. Schurgers LJ, Dissel PE, Spronk HM, et al.: Role of vitamin K and vitamin K dependent proteins in vascular calcification. Z Kardiol 2001, 90(suppl 3):57-63.
42. Stheneur C, Dumontier MF, Guedes C, et al.: Basic fibroblast growth factor as a selective inducer of matrix Gla protein gene expression in proliferative chondrocytes. Biochem J 2003, 369:63-70. The investigators explored the differential expression and regulation by insulinlike growth factor I and basic fibroblast growth factor (FGF2) of the MGP gene during chondrocyte differentiation.
43. Sarzi-Puttini P, Bevilacqua M, Atzeni F et al.: Matrix GLA protein: evidence of persistently increased concentrations in DISH patients. Arthritis Rheum 2003, 48:S534. The authors suggest that MGP may be a marker of hyperostosis in DISH patients.
44. Resnick D, ed.: Diagnosis of Bone and Joint Disorders, edn 3. Philadelphia: WB Saunders; 1995:1467-1469.
45. Yamashita Y, Takahashi M, Matsuno Y, et al.: Spinal cord compression due to ossification of ligaments: MR imaging. Radiology 1990, 175:55-60.
46. Hendrix RW, Melany M, Miller F, et al.: Fracture of the spine in patients with ankylosis due to diffuse skeletal hyperostosis: clinical and imaging findings. AJR Am J Roentgenol 1994, 162:899-904.
47. Cammisa M, De Serio A, Guglielmi G: Diffuse idiopathic skeletal hyperostosis. Eur J Radiol 1998, 27(suppl 1):S7-S11.
48. Troyanovich SJ, Buettner M: A structural chiropractic approach to the management of diffuse idiopathic skeletal hyperostosis. J Manipulat Physiol Ther 2003, 26:202-206.
49. Mears T: Acupuncture for back pain in a patient with Forestier's disease (diffuse idiopathic skeletal hyperostosis/DISH). Acupunct Med 2002, 20:102-104.
50. Price PA, Caputo JM, Williamson MK: Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. Bone Miner Res 2002, 17:1171-1179.
51. Fulton JD: Analgesic use of etidronate in Forestier's disease. Lancet 1992, 340:1287.
52. Ling TC, Parkin G, Islam J, et al.: What is the cumulative effect of long-term, low-dose isotretinoin on the development of DISH? Br J Dermatol 2001, 144:630-632.
53. Akhtar S, O'Flynn PE, Kelly A, et al.: The management of dysphagia in skeletal hyperostosis. J Laryngol Otol 2000, 114:154-157.
54. Uppal S, Wheatley AH: Transpharyngeal approach for the treatment of dysphagia due to Forestier's disease. J Laryngol Otol 1999, 113:366-368.